Supplements Marketed as Sexual Enhancement Pills Recalled
Rhino 7 3000 and Rhino 7 3000 Platinum Capsules, which are marketed as dietary supplements for sexual enhancement, have been voluntarily recalled for undeclared ingredients.
Rhino 7 3000 and Rhino 7 3000 Platinum Capsules, which are marketed as dietary supplements for sexual enhancement, have been voluntarily recalled for undeclared ingredients.
The recall affects capsules that are packaged in single 1-count blister hang tab cards with UPC #700729253748.
The FDA announced that these capsules, manufactured by California-based National Video Supply, contained undeclared desmethyl carbondenafil and dapoxetine.
Desmethyl carbondenafil is a phosphodiesterase PDE-5 inhibitor, a class of drugs used to treat male erectile dysfunction. It may interact with nitrates found in some prescription drugs, causing a drop in blood pressure.
Dapoxetine is an active ingredient that has yet to be approved for use by the FDA. Chemically, the drug belongs to the selective serotonin reuptake inhibitor (SSRI) class of drugs.
To date, National Video Supply has not received any reports of adverse effects stemming from the capsules.
However, patients can report adverse effects to the FDA’s MedWatch Adverse Event Reporting Program online, by mail, or via fax.
Consumers who have purchased these capsules can return the products to: 21100 Centre Pointe Park Way, Santa Clarita, Ca. 91350.
